I-American College of Rheumatology (ACR), ngokubambisana neYurophu League Against Against Rheumatism (EULAR), ikhuphe imilinganiselo yokuhlukanisa i-polymyalgia rheumatica ngo-Matshi 2012. Injongo kukunceda izigulane ezinemeko. Ngaphambi kokukhululwa kweendlela, kwakungekho migaqo echongiwe kakuhle okanye ehlolwe kakuhle ukuchonga izigulane ngepolymyalgia rheumatica.
Iimpawu
I-polymyalgia rheumatica yimeko yesifo se-rheumatic neentlungu ezixutywa ngamasculoskelet and stiffness entanyeni, emahlombe, nasezintanjeni ezithatha ubuncinane iiveki ezi-4. Kubantu abaninzi, i-polymyalgia rheumatica ikhula ngokuthe ngcembe, nangona abanye banokuphuhlisa iimpawu ngokukhawuleza. Ngaphandle kokuqina kobuhlungu be-musculoskeletal, iimpawu ze-polymyalgia rheumatica zingabandakanya iimpawu zendlela, iimpawu zentsholongwane (njengemfiva, i- malaise , ubuthathaka kunye nokulahleka kwesisindo).
Ukuxilongwa kunye nokuchonga
Ukuxilongwa kwe-polymyalgia rheumatica kuye kwisekelwe kwimbali yesigulane yesigulane, iimpawu zeklinikhi kunye neempawu zeemviwo kunye nokuhlolwa kwangokwenyama. Akukho vavanyo lwegazi olulodwa ukuxilonga ngokucacileyo i-polymyalgia rheumatica. Ngamanye amaxesha oogqirha bawacebisa iimvavanyo zegazi ukuze bafumane amanqanaba aphakamileyo okuvuvukala (umzekelo, isantya sedimentation okanye CRP), okanye ukulawula ezinye iintlobo ze-arthritis .
Ngaphantsi kweendlela zokukhetha ezikhutshwe yi-ACR kunye no-EULAR, isigulane sinokuthi sibe ne-polymyalgia rheumatica ukuba ngaba baneminyaka engama-50 ubudala okanye ngaphezulu, banamahlombe amaninzi, kunye negazi elingavamile kwi-CRP okanye kwi-rate ye-sedimentation, kunye nokuhlanganiswa okunye kwezi zilandelayo:
- Ukuqina koMasa kuhleli imizuzu engama-45 okanye ngaphezulu
- Ukuqala kwintlungu ye-hip okanye inqanaba elincinane lokunyakaza
- Akukho ukuvuvukala kwiindawo ezincinci zezandla kunye neenyawo
- Akukho mvavanyo egazini yegazi kwi-arthritis ye-rheumatoid (umzekelo, i- rheumatoid factor okanye i- anti-CCP antibodies )
Imilinganiselo yokuhlelwa yinkqubo ayizange yenziwe ukuba ibe yinkqubo yokuxilongwa, kodwa kunokunceda ekukhetheni izigulane kwizilingo zekliniki nokuphuhlisa iindlela zokuthambisa ezintsha zokuphatha i-polymyalgia rheumatica.
Unyango
I-polymyalgia rheumatica iphathwa ngeqondo eliphantsi lweyeza ze- corticosteroid . Oogqirha bayamisela kwaye bahlengahlengise umthamo we-steroids (ngokuqhelekileyo i- prednisone ) ukuphumeza iqondo eliphantsi kakhulu. Ngokuqhelekileyo, ukuqina okuhambisana nepolymyalgia rheumatica kukhululeka ngokukhawuleza. Uninzi lwezigulane ze-polymyalgia rheumatica ziyakwazi ukuyeka imithi ye-corticosteroid phakathi kweenyanga ezintandathu kunye neminyaka emi-2. Ukuba iimpawu ziphindaphinda, eziqhelekileyo zenzeka, i-corticosteroids inokuqalisa kwakhona. Amachiza okungafuni ukukhusela (non-steroidal anti-inflammatory drugs) (NSAIDs) angasetyenziselwa ukunyanga i-polymyalgia rheumatica, kodwa ngokuqhelekileyo, xa ithathwa yedwa, ayanele ngokwaneleyo ukulawula iimpawu.
Ngaphandle kokonyango, iimpawu ze-polymyalgia rheumatica ziyakwazi ukuqhubeka ziinyanga okanye iminyaka. Nangona unyango lwe-corticosteroid, nangona kunjalo, iimpawu zixazulula kwisithuba esinye okanye ezimbini. Ukuba i-corticosteroids ayisombululi iimpawu, ugqirha unokucinga ngokunye ukuxilongwa.
Ukukhula
Abasetyhini abaseCaucasus kunye nabangaphezu kweminyaka engama-50 banomngcipheko omkhulu wokuphuhlisa i-polymyalgia rheumatica okanye i- giant cell arteritis (imeko ehambelana nayo). EUnited States, kulinganiselwa ukuba ama-700 kubantu abayi-100 000 abangaphezu kwe-50 kubemi jikelele bahlakulela ipolymyalgia. Kuyinto inqabile ukuba umntu oneminyaka engaphantsi kwe-50 ubudala akhule ipolymyalgia rheumatica.
I-polymyalgia rheumatica ichaphazela isiguli esifanayo nesigxina se-cell arteritis, kodwa i-polymyalgia rheumatica ivela ezimbini ukuya kathathu ngokuphindaphindiweyo kune-giant cell arteritis. Bobabini i-polymyalgia rheumatica kunye ne-giant cell arteritis ihlelwa njenge- vasculitides (iqela leemeko ezibonakaliswa ukuvuvukala kwemithambo yegazi).
Imithombo:
2012 Inkqubo yokuhlengahlengisa i-polymyalgia rheumatica: I-European League ngokumelene neRheumatism / i-American College yeRheumatology inxaxheba. Dasgupta B. et al. Arthritis & Rheumatism. Epreli 2012.
Imibuzo neempendulo ngePolymyalgia Rheumatica kunye neGiant Cell Arteritis. Isiko seSizwe seArthritis kunye neMisculoskeletal kunye Nezifo Zesikhumba. Epreli 2010.
Polymyalgia Rheumatica. Ikholeji yaseMerika yaseRheumatology. UWilliam P. Docken, MD. Ukuhlaziywa kukaAgasti 2009.
I-Primer kwi-Rheumatic Diseases. Polymyalgia Rheumatica. Amaphepha 404-406. Klippel J. et al. Uluhlu lweSithathu. Ipapashwe ngu-Arthritis Foundation.